The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2023

Filed:

May. 19, 2020
Applicant:

Just-evotec Biologies, Inc., Seattle, WA (US);

Inventors:

Tileli Amimeur, Seattle, WA (US);

Randal Robert Ketchem, Snohomish, WA (US);

Jeremy Martin Shaver, Lake Forest Park, WA (US);

Rutilio H. Clark, Bainbridge Island, WA (US);

John Alex Taylor, Bellevue, WA (US);

Assignee:

Just-Evotec Biologics, Inc., Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 40/20 (2019.01); G16B 20/30 (2019.01); G06N 3/12 (2006.01); G06N 3/123 (2023.01);
U.S. Cl.
CPC ...
G16B 40/20 (2019.02); G06N 3/123 (2013.01); G16B 20/30 (2019.02);
Abstract

Amino acid sequences of antibodies can be generated using a generative adversarial network that includes a first generating component that generates amino acid sequences of antibody light chains and a second generating component generates amino acid sequences of antibody heavy chains. Amino acid sequences of antibodies can be produced by combining the respective amino acid sequences produced by the first generating component and the second generating component. The training of the first generating component and the second generating component can proceed at different rates. Additionally, the antibody amino acids produced by combining amino acid sequences from the first generating component and the second generating component may be evaluated according to complentarity-determining regions of the antibody amino acid sequences. Training datasets may be produced using amino acid sequences that correspond to antibodies have particular binding affinities with respect to molecules, such as binding affinity with major histocompatibility complex (MHC) molecules.


Find Patent Forward Citations

Loading…